Additionally, we find that while ERBB3 and ERBB2 are affected by the treatment, EGFR was not, further reiterating our previous results that an ERBB3/ERBB2 signaling cascade operates in melanoma and is mostly responsible of the activation of PI3K/AKT signaling [2]. The gene discussed is ERBB3; the disease is melanoma.